Abstract
The composition and spatial orientation of extracellular matrix vary for each tissue type. In bone, it mainly consists of an organic phase, known as osteoid, which represents approximately 20 % of bone mass, and a mineral phase. The organic fraction of bone consists of over 90 % type I collagen, other minor collagens such as types III and V, and 5 % non-collagenous proteins. The non-collagenous proteins in bone include osteocalcin, osteonectin, alkaline phosphatase, osteopontin, bone sialoprotein, dental matrix protein 1, fibronectin, thrombospondin, vitronectin, and fibrillin. The mineral phase of bone is mostly hydroxyapatite [Ca10(PO4)6(OH)2], with small amounts of carbonate, magnesium, and acid phosphate, a calcium phosphate compound. The bone matrix also sequesters growth factors, acting as a reservoir for soluble inductive signals such as bone morphogenic protein. This chapter discusses (1) bone matrix proteins and (2) mineralization process.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Niyibizi C, Eyre DR (1994) Structural characteristics of crosslinking sites in type V collagen of bone chain specificities and heterotypic links to type I collagen. Eur J Biochem 224:943–950
Pace JM, Chitayat D, Atkinson M, Wilcox WR et al (2002) A single amino acid substitution (D1441Y) in the carboxyl-terminal propeptide of the proa1(I) chain of type I collagen results in a lethal variant of osteogenesis imperfecta with features of dense bone diseases. J Med Genet 39:23–29
Uitto J, Kouba D (2000) Cytokine modulation of extracellular matrix gene expression: relevance to fibrotic skin diseases. J Dermatol Sci 24:S60–S69
Myllyharju J, Kivirikko KI (2001) Collagens and collagen-related diseases. Ann Med 33:7–21
Asish K, Ghosh AK (2002) Factors involved in the regulation of type I collagen gene expression: implication in fibrosis. Exp Biol Med 227:301–314
Shekaran A, García AJ (2011) Extracellular matrix-mimetic adhesive biomaterials for bone repair. J Biomed Mater Res A 96(1):261–272
Zhu W, Robey PG, Boskey AL (2007) The regulatory role of matrix proteins in mineralization of bone. Osteoporosis, Vol 1. Academic Press, San Diego, pp 191–240
Clemens TL, Karsenty G (2011) The osteoblast: an insulin target cell controlling glucose homeostasis. J Bone Miner Res 26(4):677–680
Ducy P, Desbois C, Boyce B et al (1996) Increased bone formation in osteocalcin-deficient mice. Nature 382:448–452
Boskey AL, Gadaleta S, Gundberg C et al (1998) Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 23:187–196
Ishida M, Amano S (2004) Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation. J Bone Miner Metab 22:415–429
Kaisa KI et al (2004) Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro. J Biol Chem 279:18361–18369
Lee NK, Sowa H, Hinoi E et al (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 30:456–469
Ferron M, Wei J, Yoshizawa T et al (2010) Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142:296–308
Boström K et al (2001) Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells. J Biol Chem 276:14044–14052
Price PA (1989) Gla-containing proteins of bone. Connect Tissue Res 21:51–69
Luo G, Ducy P, McKee MD et al (1997) Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386:78–81
El-Maadawy S, Kaartinen MT, Schinke T et al (2003) Cartilage formation and calcification in arteries of mice lacking matrix Gla protein. Connect Tissue Res 44:272–278
Sodek KL, Tupy JH, Sodek J et al (2000) Relationships between bone protein and mineral in developing porcine long bone and calvaria. Bone 26:189–198
Delany AM, Hankenson KD (2009) Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone remodeling. J Cell Commun Signal 3:227–238
Butch AW, Goodnow TT, Brown WS et al (1989) Stratus automated creatine kinase-MB assay evaluated: identification and elimination of falsely increased results associated with a high-molecular-mass form of alkaline phosphatase. Clin Chem 35(10):2048–2053
Bonucci E, Silvestrini G, Bianco P (1992) Extracellular alkaline phosphatase activity in mineralizing matrices of cartilage and bone: ultrastructural localization using a cerium-based method. Histochemistry 97:323–327
Fedde KN, Blair L, Silverstein J et al (1999) Whyte: alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 14:2015–2026
Jaffe IZ, Tintut Y, Newfell BG et al (2007) Mineralocorticoid receptor activation promotes vascular cell calcification. Arterioscler Thromb Vasc Biol 27:799–805
Shao JS, Cai J, Towler DA (2006) Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol 26:1423–1430
Negrao MR, Keating E, Faria A et al (2006) Acute effect of tea, wine, beer, and polyphenols on ecto-alkaline phosphatase activity in human vascular smooth muscle cells. J Agric Food Chem 54:4982–4988
Sodek J, Ganss B, McKee MD (2000) Osteopontin. Crit Rev Oral Biol Med 11:279–303
Jono S, Peinado C, Giachelli CM (2000) Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem 275:20197–20203
Ishijima M, Rittling SR, Yamashita T et al (2001) Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin. J Exp Med 193:399–404
Haylock DN, Nilsson SK (2006) Osteopontin: a bridge between bone and blood. Br J Haematol 34(5):467–474
Sodek J, Chen J, Kasugai S et al (1992) Elucidating the functions of bone sialoprotein and osteopontin in bone formation. In: Slavkin H, Price P (eds) Chemistry and biology of mineralized tissues. Elsevier, Amsterdam, pp 297–306
Oldberg A, Franzen A, Heinegard D (1988) The primary structure of a cell-binding bone sialoprotein. J Biol Chem 263(36):19430–19432
Raynal C, Delmas PD, Chenu C (1996) Bone sialoprotein stimulates in vitro bone resorption. Endocrinology 137(6):2347–2354
Malaval L, Wade-Guèye NM, Chen F et al (2008) Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis. J Exp Med 205:1145–1153
Seibel MJ, Woitge HG et al (1996) Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone disease. J Clin Endocrinol Metab 81:3289–3294
Wolfgang W, Armbruster FP et al (1997) Bone sialoprotein in serum of patients with malignant bone disease. Clin Chem 43:85–91
Qin C, Huang B, Wygant JN et al (2006) A chondroitin sulfate chain attached to the bone dentin matrix protein 1 NH2-terminal fragment. J Biol Chem 281(12):8034–8040
Gericke A, Qin C, Sun Y et al (2010) Different forms of DMP1 play distinct roles in mineralization. J Dent Res 89:355–359
Tartaix PH et al (2004) In vitro effects of dentin matrix protein 1 on hydroxyapatite formation provide insights into in vivo function. J Biol Chem 279:18115–18120
Narayanan K et al (2003) Dual functional roles of dentin matrix protein 1: implications in biomineralization and gene transcription by activation of intracellular Ca2+ store. J Biol Chem 278:17500–17508
Ye L, MacDougall M, Zhang S et al (2004) Deletion of dentin matrix protein-1 leads to a partial failure of maturation of predentin into dentin, hypomineralization, and expanded cavities of pulp and root canal during postnatal tooth development. J Biol Chem 279(18):19141–19148
Ye L, Mishina Y, Chen D et al (2005) Dmp1-deficient mice display severe defects in cartilage formation responsible for a chondrodysplasia-like phenotype. J Biol Chem 280(7):6197–6203
Jain A, Fedarko NS, Collins MT et al (2004) Serum levels of matrix extracellular phosphoglycoprotein (MEPE) in normal humans correlate with serum phosphorus, parathyroid hormone and bone mineral density. J Clin Endocrinol Metab 89:4158–4161
Martin A, David V, Laurence JS et al (2008) Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP. Endocrinology 149:1757–1772
Martin A, David V, Laurence JS et al (2008) Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP. Endocrinology 149:1757–1772
Addison WN, Nakano Y, Loisel T et al (2008) MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM. J Bone Miner Res 23:1638–1649
David V, Martin A, Hedge AM et al (2009) Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator. Endocrinology 150:4012–4023
Stein GS, Lian JB (1993) Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 14:424–442
Velling T, Risteli J, Wennerberg K et al (2002) Polymerization of type I and III collagens is dependent on fibronectin and enhanced by integrins α11β1 and α2β1. J Biol Chem 277:37377–37381
Sottile J, Hocking DC (2002) Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol Biol Cell 13:3546–3559
Couchourel D et al (1999) Effects of fibronectin on hydroxyapatite formation. J Inorg Biochem 73:129–136
Bentmann A, Kawelke N, Moss D et al (2010) Circulating fibronectin affects bone matrix, whereas osteoblast fibronectin modulates osteoblast function. J Bone Miner Res 25(4):706–715
Armstrong LC, Bornstein P (2003) Thrombospondins 1 and 2 function as inhibitors of angiogenesis. Matrix Biol 22:63–71
Hankenson KD, Bain SD, Kyriakides TR et al (2000) Increased marrow-derived osteoprogenitor cells and endosteal bone formation in mice lacking thrombospondin 2. J Bone Miner Res 15:851–862
Hankenson KD, Bornstein P (2002) The secreted protein thrombospondin 2 is an autocrine inhibitor of marrow stromal cell proliferation. J Bone Miner Res 17:415–425
Alford AI, Terkhorn SP, Reddy AB, Hankenson KD (2010) Thrombospondin-2 regulates matrix mineralization in MC3T3- E1 pre-osteoblasts. Bone 46:464–471
Hess S, Kanse SM, Kost C et al (1995) The versatility of adhesion receptor ligands in haemostasis: morpho-regulatory functions of vitronectin. Thromb Haemost 74:258–265
Schvartz I, Seger D, Shaltiel S (1999) Vitronectin. Int J Biochem Cell Biol 31(5):539–544
Ramirez F, Pereira L et al (1999) The fibrillins. Int J Biochem Cell Biol 31:255–259
Boskey AL (1998) Biomineralization: conflicts, challenges, and opportunities. J Cell Biochem 30:83–91
Harmey D, Hessle L, Narisawa S et al (2004) concerted regulation of inorganic pyrophosphate and osteopontin by Akp2, Enpp 1, and Ank: an integrated model of the pathogenesis of mineralization disorders. Am J Pathol 164:1199–1209
Tesch W, Vandenbos T, Roschgr P et al (2003) Orientation of mineral crystallites and mineral density during skeletal development in mice deficient in tissue nonspecific alkaline phosphatase. J Bone Miner Res 18:117–125
Santini D, Pantano F, Vincenzi B et al (2012) The role of bone microenvironment, vitamin D and calcium. Recent Results Cancer Res 192:33–64
Liu S, Tang W, Zhou J et al (2006) Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 17:1305–1315
Shimada T, Kakitani M, Yamazaki Y et al (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest. 113:561–568
Wang H, Yoshiko Y, Yamamoto R et al (2008) Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. J Bone Miner Res 23:939–948
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Italia
About this chapter
Cite this chapter
Tamma, R., Carbone, C., Colucci, S. (2014). Bone Matrix Proteins and Mineralization Process. In: Albanese, C.V., Faletti, C. (eds) Imaging of Prosthetic Joints. Springer, Milano. https://doi.org/10.1007/978-88-470-5483-7_2
Download citation
DOI: https://doi.org/10.1007/978-88-470-5483-7_2
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5482-0
Online ISBN: 978-88-470-5483-7
eBook Packages: MedicineMedicine (R0)